ABAXIS, INC.

FDA Device Registration & Listing · UNION CITY, CA, US · Registration 2939693

Public Record Device Listing Expiry Year: 2026 This page presents structured fields from public FDA datasets.

Registration Header Parameters

Normalized identity and public registration information from FDA records.

Source
FDA Device Registration & Listing
Record Type
Device registration/listing
Registration Number
2939693
FEI Number
2939693
Entity Name
ABAXIS, INC.
City/State/Country
UNION CITY, CA, US
Establishment Address
3240 WHIPPLE RD., UNION CITY, CA 94587, US
Establishment Type(s)
Manufacture Medical Device
Owner / Operator
ZOETIS, INC. (Owner Number: 9000378)
Owner / Operator Contact Address
3240 WHIPPLE RD., --, Union City, CA 94587, US
Initial Importer Flag
N
Expiration Date (Year)
2026
510(k) Number
PMA Number
N/A

All Registered Proprietary Names

PICCOLO CHLORIDE TEST SYSTEM PICCOLO PHOSPHORUS TEST SYSTEM Piccolo CRP Test System PICCOLO MAGNESIUM TEST SYSTEM PICCOLO TRIGLYCERIDE TEST SYSTEM PICCOLO HIGH DENSITY LIPOPROTEIN (H Aspartate Aminotransferase (AST) Uric Acid Piccolo Xpress PICCOLO GGT TEST SYSTEM PICCOLO PRIMARY HEALTH PANEL Piccolo Uric Acid Test System PICCOLO LACTATE DEHY Piccolo Lactate Test System Total Carbon Dioxide Creatine Kinase Enzymatic Potassium

Registered Product Listings

Product Code Device Name Medical Specialty Device Class Regulation Number Created Date
CHJ Mercuric Thiocyanate, Colorimetry, Chloride Clinical Chemistry Class 2 862.1170 2009-03-27
CEO Phosphomolybdate (Colorimetric), Inorganic Phosphorus Clinical Chemistry Class 1 862.1580 2006-01-10
DCN System, Test, C-Reactive Protein Immunology Class 2 866.5270 2010-03-26
JGJ Photometric Method, Magnesium Clinical Chemistry Class 1 862.1495 2006-01-10
JGY Colorimetric Method, Triglycerides Clinical Chemistry Class 1 862.1705 2003-06-30
LBS Ldl & Vldl Precipitation, Cholesterol Via Esterase-Oxidase, Hdl Clinical Chemistry Class 1 862.1475 2003-06-30
JJG Analyzer, Chemistry, Centrifugal, For Clinical Use Clinical Chemistry Class 1 862.2140 2006-01-20
JQB Kinetic Method, Gamma-Glutamyl Transpeptidase Clinical Chemistry Class 1 862.1360 2001-05-21
CJY Azo Dye, Calcium Clinical Chemistry Class 2 862.1145 2007-05-30
CEK Biuret (Colorimetric), Total Protein Clinical Chemistry Class 2 862.1635 2007-05-30
CHH Enzymatic Esterase--Oxidase, Cholesterol Clinical Chemistry Class 1 862.1175 2007-05-30
CIG Diazo Colorimetry, Bilirubin Clinical Chemistry Class 2 862.1110 2007-05-30
CDN Urease, Photometric, Urea Nitrogen Clinical Chemistry Class 2 862.1770 2007-05-30
CKF Phenylphosphate, Alkaline Phosphatase Or Isoenzymes Clinical Chemistry Class 2 862.1050 2007-05-30
CGA Glucose Oxidase, Glucose Clinical Chemistry Class 2 862.1345 2007-05-30
CJW Bromcresol Purple Dye-Binding, Albumin Clinical Chemistry Class 2 862.1035 2007-05-30
CGX Alkaline Picrate, Colorimetry, Creatinine Clinical Chemistry Class 2 862.1225 2007-05-30
CIJ Saccharogenic, Amylase Clinical Chemistry Class 2 862.1070 2007-05-30
CKA Nadh Oxidation/Nad Reduction, Alt/Sgpt Clinical Chemistry Class 1 862.1030 2007-05-30
CEM Electrode, Ion Specific, Potassium Clinical Chemistry Class 2 862.1600 2007-05-30
KNK Acid, Uric, Uricase (Colorimetric) Clinical Chemistry Class 1 862.1775 2015-04-30
CFJ Nad Reduction/Nadh Oxidation, Lactate Dehydrogenase Clinical Chemistry Class 2 862.1440 2006-01-10
KHP Acid, Lactic, Enzymatic Method Clinical Chemistry Class 1 862.1450 2013-05-02
KHS Enzymatic, Carbon-Dioxide Clinical Chemistry Class 2 862.1160 2012-03-29
CEM Electrode, Ion Specific, Potassium Clinical Chemistry Class 2 862.1600 2012-03-29
JLB Atp And Creatine Kinase (Enzymatic), Creatine Clinical Chemistry Class 1 862.1210 2012-03-29

Official Correspondent

No official correspondent registered.

US Agent Details

No US Agent registered (Local establishment).

Related Public Records

Same Entity

ZOETIS, INC.
View consolidated registration, premarket clearance, and recall records for this applicant.
View Entity Profile →

Related 510(k) Records

510(k) Number Applicant Device Name Decision Date
K083412 Mitsubishi Kagaku Iatron PATHFAST HSCRP 2009-03-09
K881300 Medical Analysis Systems, Inc. MAGNESIUM LIQUID STABLE REAGENT SET 1988-05-17
K162399 Siemens Healthcare Diagnostics, Inc. Atellica CH Magnesium (Mg) 2017-01-19
K861663 Data Medical Associates, Inc. TOTAL PROTEIN PROCEDURE 1986-06-13
K832169 Sandare Chemical Co., Inc. TOTAL PROTEIN PROCEDURE 1983-08-16

Related Recall Records

Recall ID Recalling Firm Recall Class Product Description
Z-0020-2014 Abbott Laboratories, Inc 1
Clinical Chemistry Phosphorus Reagent The Phosphorus assay is used for the quantitation of phosphorus in human serum, plasma, or urine.
Z-0010-2009 Roche Diagnostics Corp. 1
Roche Diagnostics HDLC3, HDL-Cholesterol Plus 3rd Generation, COBAS INTEGRA, cobas c systems, Roche Diagnostics, Indianapolis, IN.; 04399803190. An in-vitro diagnostic reagent system intended for use on COMAS Integra systems for the quantitative determination of HDL-cholesterol in serum and plasma.
Z-0378-06 Instrumentation Laboratory Co. 2
GEM PREMIER 3000
Z-2165-2011 Instrumentation Laboratory Co. 2
Instrumentation Laboratory GEM Premier 4000 PN 00025000000 The GEM Premier 4000 is a portable critical care system for use by health care professionals to rapidly analyze whole blood samples at the point of health care delivery in a clinical setting and in a central laboratory. The instrument provides quantitative measurements of pH, pC02, p02, sodium, potassium, chloride, ionized calcium, glucose, lactate, hematocrit, total bilirubin and CO-OXimetry (tHb, 02Hb, COHb, MetHb, HHb) parameters. Total bilirubin can also be quantitated from heparinized plasma samples when analyzed in the tBili/CO-Ox mode. These parameters, along with derived parameters, aid in the diagnosis of a patient's acidlbase status, electrolyte and metabolite balance and oxygen delivery capacity. Total bilirubin measurements are used in the diagnosis and management of biliary tract obstructions, liver disease and various hemolytic diseases and disorders involving the metabolism of bilirubin. In neonates, the level of total bilirubin is used to aid in assessing the risk of kernicterus
Z-0012-2009 Roche Diagnostics Corp. 2
Roche Diagnostics NAPA2, N-Acetyl-Procainamide, COBAS INTEGRA, Roche Diagnostics, Indianapolis, IN.; 20737852322. An in-vitro diagnostic reagent system intended for use on COBAS Integra systems for the qualitative determination of NAPA in serum or plasma.

Similar Registrations

Registration Number Establishment Name Location
1616487 STANBIO LABORATORY Boerne, TX, US
3006198300 Diamond Diagnostics Inc. Budapest, HU
1181121 Fisher Diagnostics MIDDLETOWN, VA, US
1063851 MERCEDES MEDICAL LLC Lakewood Ranch, FL, US
3013660430 High Technology, Inc. North Attleboro, MA, US
Source Citation & Summary: This public preview is extracted from openFDA device registration and listing logs under registration number 2939693. Last updated year: 2026. Please use registration number 2939693 when referencing this establishment in official correspondence.
Legal Disclaimer: AvaSpecs is not affiliated with the FDA or any government agency and does not provide medical, legal, regulatory, safety, approval, clearance, effectiveness, endorsement, or compliance advice. This index page is built using public record archives and does not represent an official regulatory determination.
Account Required Full available specs will require a free AvaSpecs account.